Analysis of dulaglutide efficacy and safety for weight reduction in diabetic patients confirms meaningful weight loss with acceptable tolerability profile.
Key findingAnalysis of dulaglutide efficacy and safety for weight reduction in diabetic patients confirms meani
What the researchers found
Analysis of dulaglutide efficacy and safety for weight reduction in diabetic patients confirms meaningful weight loss with acceptable tolerability profile.
Why it matters
Relevant to peptide-based therapeutic applications.
The numbers in context
Retrospective study from Saudi Arabia measuring weight loss and glycemic control outcomes with dulaglutide in T2D patients.
How the study worked
Methodology in publication.
Who was studied
Adults with type 2 diabetes in Saudi Arabia treated with dulaglutide
What this study cannot tell us
Limitations in publication.
How to read the evidence
Based on study design.
When this study was published
Published in 2025.
The bigger picture
Contributes to peptide therapeutic evidence.
Questions still open
- Long-term implications?
- Comparison to evidence?
- Next research?
Common questions
What does this mean?
How reliable?
Read the original research
Efficacy and Safety of Dulaglutide for Weight Reduction Among Diabetic Patients in Saudi Arabia: A Retrospective Cohort Study.
Cureus, 17(7), e88424
Citation
Alonazi, Gadah K; Alawuad, Lamia A. (2025). Efficacy and Safety of Dulaglutide for Weight Reduction Among Diabetic Patients in Saudi Arabia: A Retrospective Cohort Study.. Cureus, 17(7), e88424. https://doi.org/10.7759/cureus.88424